Researcher
Dr. Ania M. Jastreboff
Yale University School
Biography & Research Background
Ania M. Jastreboff, MD, PhD, is an Associate Professor at Yale University School of Medicine (New Haven, CT, USA) and Director of the Yale Obesity Research Center. She is the lead author of the 2023 New England Journal of Medicine publication on the triple-hormone-receptor agonist retatrutide (LY3437943) and is widely cited in the incretin and multi-receptor agonist research literature. Her published research focuses on the neuroendocrine regulation of appetite, energy balance and metabolic signaling, and she has contributed to the scientific literature on several investigational incretin-based peptides, including GIP, GLP-1 and glucagon receptor agonists. Ania M. Jastreboff is being referenced as one of the leading scientists involved in retatrutide research. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between SHR3D Aminos and this doctor.
External Profiles
Authored Research Profiles (2)
Dr. Ania M. Jastreboff is referenced as a leading researcher in the following peptide research profiles on SHR3D Aminos:
Disclaimer
Dr. Ania M. Jastreboff is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between SHR3D Aminos and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.